Publication

Video

Sponsored

Federal Equipment Company: Supporting CDMO Operations Through Training, Parts, and Equipment

Author(s):

Federal Equipment Company
Conference|DCAT

Adam Covitt, President of Federal Equipment Company, discusses how the company enables CDMO successes with its Techceuticals and PharmParts business brands.

At a recent Drug, Chemical & Associated Technologies (DCAT) conference, Pharmaceutical Technology spoke with Adam Covitt, President of Federal Equipment Company, to hear the latest in the CDMO landscape. Learn more about:

  • An introduction/re-introduction to Federal Equipment Company.
  • Challenges and opportunities in the 2024 CDMO landscape.
  • How Federal Equipment Company can assist CMDO success with its Techceuticals and PharmParts business brands.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content
3d render. Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. COVID-19 mRNA vaccine production platform. | Image Credit: © wacomka - stock.adobe.com
July 22nd 2025

Pack Expo Las Vegas Marks 30th Anniversary with New Experiences for 2025

Patrick Lavery
The trade show is expected to draw 35,000 attendees to a show floor netting more than 1 million square feet.
How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)
November 29th 2022

How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)

Chris Spivey
Allison Labriola, Senior Technical Sales Representative, at JRS Pharma is interviewed by the Editorial Director of Pharmaceutical Technology Chris Spivey about how the food industry is affecting the pharmaceutical industry.
A lab technician in protective gear operates a tablet displaying a green checkmark in a high-tech pharmaceutical laboratory. | Image Credit: © greenbutterfly - stock.adobe.com
May 29th 2025

Companies Reveal Their Next Moves in Manufacturing

Patrick Lavery
In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.
A doctor in a white lab coat shaking hand showing symbol of medicine innovation, treatment, discovery and healthcare analysis. | Image Credit: © chadchai - stock.adobe.com
May 28th 2025

Geopolitical Shifts Change Nature of Pharma Partnerships

Patrick Lavery
The concerns of industry experts expressed at INTERPHEX in April 2025 are still pertinent in an uncertain global political climate.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com
May 5th 2025

GSK Previews Oral and Poster Abstracts for ATS International Congress

Patrick Lavery
The company is presenting data related to its medications designed to advance the prevention and treatment of asthma and COPD.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com
April 29th 2025

Capsida Previews Its Oral and Poster Presentations for ASGCT 2025

Patrick Lavery
The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.